Holy Mackerel! This week we will discuss fish oil use in maintenance hemodialysis patients. Could this be the one thing that bends the curve on CV mortality, or is it just a red herring?

This week, we will discuss the phase 3 ORIGIN3 trial of atacicept, an APRIL/BAFF inhibitor for use in IgAN.

We like protein, or do we? Low protein, high protein, supplements…what’s a nephrologist to do?

Preeclampsia Treatment, Eclampsia, Eclampsia Treatment, Toxemia, PET and PIH, HELLP Syndrome, Causes Preeclampsia, Preeclampsia Affect Pregnancy, Preeclampsia Affect the Baby

In just over a decade of critical appraisal on NephJC, we have done several experiments. Some of them have worked out phenomenally well, such as the Freely Filtered podcast. Others were not ready for ...

Background The global prevalence of end-stage kidney disease (ESKD) is increasing despite optimal management of traditional risk factors such as hyperglycaemia, hypertension, and dyslipidaemia. This s...